Genetic Engineering and Biotechnology News

Dr. David Bearss, from SuperGen

talks with GEN’s Editor-in-Chief John Sterling about tackling bottlenecks in small-molecule drug discovery research.

PodcastsResourcesDrug discoveryDrug research and developmentGenetic Engineering and BiotechnologyGenetic researchGeneticsPharmacologySmall molecules
Also of Interest
Talus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics
Tautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
Lilly's GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Related Media
Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability
Reporting Live from JPM 2026: Alex Philippidis and Jonathan Grinstein, PhD
AI in Protein Design: Hype vs. Reality Explained by David Baker
The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera
Genetics in DC: A Report from ASHG
Celebrating DNA: Matthew Cobb's Reflections on the Double Helix